Webinars > All COMPLIANCE Categories > Compliance Courses Webinars 
Compliance 4 All presents
 Responsibility for Off-label Claims in Social Media Webinar
By attending this webinar, you will learn how the social media can be potential violators of the FDA’s requirements on labeling. This webinar will also explain how third parties can place you in jeopardy. You will understand the FDA's concerns about "fair and balanced" information and ways to define your social media responsibilities
Course Description/Agenda
Responsibility for Off-label Claims in Social Media
Overview:
FDA's sweeping definition of labeling includes what is said or represented, even by images, in a social media platform.
If the information can reach a consumer, FDA cares, even if you did not publish the information. Firm's need to watch for promotional trespassers. Websites, chat rooms, op-ed articles or even your own postings in social media can cause your product to be misbranded, i.e., illegal.
One big issue is how you patrol and control what someone else is saying about your product in a public forum. Once the off-label information is out there, what is scope your responsibility?
Why should you Attend:
- What is considered "off-label"
- Using social media website "likes" and links
- Direct to Consumer promotion pitfalls
- Fair and balanced information
Areas Covered in the Session:
- Understand how social media is labeling
- Learn how third parties place you in jeopardy
- Understand FDA's concern about "fair and balanced" information
- Ways to define your social media responsibilities
- Apply FDA Guidance Documents on DTC / social media labeling
Who Will Benefit:
-
- Regulatory Affairs Directors
- Marketing Directors
- Sales Managers
- Website Managers
- Importers
- Clinical Establishments/Institutions
- Clinical Sponsors
- Quality Assurance Managers
Casper (Cap) Uldriks, through his firm "Encore Insight LLC," brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. His comments are candid, straightforward and of practical value. He understands how FDA thinks, how it operates and where it is headed. Based on his exceptionally broad experience and knowledge, he can synthesize FDA's domestic and international operational programs, institutional policy and thicket of legal variables into a coherent picture. Professional credentials: JD - Suffolk University, licensed in Massachusetts and the District of Columbia; M.Div in psychology - Boston University with internship through Harvard University.
|
More Webinar Information |
|
Compliance 4 All
|
Course Summary |
By attending this webinar, you will learn how the social media can be potential violators of the FDA’s requirements on labeling. This webinar will also explain how third parties can place you in jeopardy. You will understand the FDA's concerns about "fair and balanced" information and ways to define your social media responsibilities |
Delivery
Method |
Virtual Classroom (Live) |
Who Should Attend |
• Regulatory Affairs Directors
• Marketing Directors
• Sales Managers
• Website Managers
• Importers
• Clinical Establishments/Institutions
• Clinical Sponsors
• Quality Assurance Managers
|
|
|
 Search similar training
 Email this page
 Print this document
Frequently Asked
Questions
Payment Options
Bill Me/Invoice
Credit Card
Register
Online
Fax Form
Availability
Select a date from the list at the bottom of the page for specific information about that class.
Other Information
Virtual Classroom (Live) |
|
